Workflow
and solutions
icon
Search documents
Genpact to Report Second Quarter 2025 Results
Prnewswire· 2025-07-10 20:05
NEW YORK, July 10, 2025 /PRNewswire/ -- Genpact (NYSE: G) will report its financial results for the second quarter ended June 30, 2025 after the close of the U.S. financial markets on Thursday, August 7, 2025. Following the release, Genpact's management team will host a conference call at 5:00 p.m. ET to discuss the company's performance.Participants are encouraged to register in advance to receive a dial-in number and unique PIN for seamless access. While early log-in is recommended, registration and acces ...
Genpact Recognized as One of America's Best Midsize Companies by TIME
Prnewswire· 2025-07-10 17:00
Core Insights - Genpact has been included in TIME's America's Best Midsize Companies 2025 list, marking its second recognition, which highlights the company's commitment to innovation, employee satisfaction, and sustainability transparency [1][2] Group 1: Company Recognition - Genpact's inclusion in the TIME list reflects its strong performance in revenue growth, employee satisfaction, and sustainability transparency, which are critical parameters for scoring [1][2] - The company operates within a revenue range of $100 million to $10 billion, as highlighted by the TIME and Statista collaboration [2] Group 2: Leadership Statements - Balkrishan "BK" Kalra, President and CEO of Genpact, emphasized the importance of a dynamic and inclusive employee culture, sustained innovation, and exceptional client value as key factors for this recognition [2] Group 3: Company Overview - Genpact is described as an advanced technology services and solutions company that aims to deliver lasting value for enterprises globally through operational excellence and cutting-edge solutions [3] - The company leverages data, technology, and AI to drive innovation and create future solutions [3]
Wesco Announces Second Quarter 2025 Earnings Call
Prnewswire· 2025-07-10 10:00
PITTSBURGH, July 10, 2025 /PRNewswire/ -- Wesco International (NYSE: WCC) will hold its second quarter 2025 earnings conference call on Thursday, July 31 at 10:00 a.m. ET. Dial-in details are below. The live audio webcast of the earnings presentation can be accessed at https://investors.wesco.com where related materials will be posted prior to the presentation, and a replay of the webcast will be available.Second Quarter Earnings Call Dial-In AccessLive AccessNorth America Toll Free: 1-877-443-5356Internati ...
Here's Why Allegion (ALLE) is a Strong Momentum Stock
ZACKS· 2025-07-09 14:50
It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different ways to do both.The research service features daily updates of the Zacks Rank and Zacks Industry Rank, full access to the Zacks #1 Rank List, Equity Research reports, and Premium stock screens, all of which will help you become a smarter, more confident investor.It also includes access to the Zacks Style Scores. ...
Ryan Specialty (RYAN) - 2021 Q3 - Earnings Call Presentation
2025-07-08 12:40
Company Overview - Ryan Specialty Group (RSG) is a rapidly growing provider of specialty products and solutions for insurance brokers, agents, and carriers[11] - RSG was founded in 2010[12] - As of September 30, 2021, RSG's LTM (Last Twelve Months) revenue was $1.4 billion[12] - RSG is the 2nd largest U S P&C wholesale broker[12] Financial Performance - RSG's organic revenue growth for the period ending September 30, 2021, YTD (Year-to-Date) was 25 6%[12] - RSG's LTM total revenue growth as of September 30, 2021, was 51 6%[12] - The Adjusted EBITDAC for LTM was $442 million[49] - The Adjusted EBITDAC Margin was 32 0%[49] Market Position and Growth Strategy - 71% of RSG's premiums are placed in the attractive E&S (Excess & Surplus) market[19] - The E&S market has experienced a CAGR (Compound Annual Growth Rate) of 6 4% compared to the admitted market's CAGR of 4 0% over the past decade[21] - RSG's revenue growth with the top 100 retail brokerage firms exceeded RSG's organic revenue growth of 20% in 2020[31] - RSG has completed over 40 acquisitions since its founding[31]
Ryan Specialty (RYAN) - 2021 Q2 - Earnings Call Presentation
2025-07-08 12:38
Company Overview - Ryan Specialty Group (RSG) was founded in 2010 and has grown to $1 billion in revenue by 2020[12] - RSG is the 2nd largest U S P&C wholesale broker and the largest U S P&C MGU[12] - The company experienced 20% organic revenue growth in 2020[12] - Total revenue growth in 2020 was 33%[12] Market Position and Strategy - 71% of RSG's premiums are placed in the E&S market[20] - The E&S market has a Compound Annual Growth Rate (CAGR) of 6 4% compared to the admitted market's 4 0% over the past decade[23] - RSG's revenue growth with the top 100 retail brokerage firms exceeded RSG's organic revenue growth of 20% in 2020[31] - Approximately $59 million of revenue was acquired in 2019, and $240 million in 2020 through strategic acquisitions[31] Financial Performance - Adjusted EBITDAC increased from $191 million in 2019 to $294 million in 2020[40] - The Adjusted EBITDAC Margin increased from 25% in 2019 to 29% in 2020[40] - The company's revenue increased from $765 million in 2019 to $1 018 billion in 2020[40]
Robbins LLP Reminds Petco Health and Wellness Company, Inc. Investors with Large Losses to Contact the Firm for Information About the WOOF Class Action Lawsuit
GlobeNewswire News Room· 2025-07-07 20:59
SAN DIEGO, July 07, 2025 (GLOBE NEWSWIRE) -- Robbins LLP reminds stockholders that a class action was filed on behalf of investors who purchased or otherwise acquired Petco Health and Wellness Company, Inc. (NASDAQ: WOOF) securities between January 14, 2021 and June 5, 2025. Petco is a specialty retailer that offers a variety of pet products, services, and solutions. For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003. The Allegations: Robbins LLP is Inv ...
Pomerantz Law Firm Announces the Filing of a Class Action Against Petco Health and Wellness Company, Inc. and Certain Officers - WOOF
Prnewswire· 2025-07-07 17:58
NEW YORK, July 7, 2025 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Petco Health and Wellness Company, Inc. ("Petco" or the "Company") (NASDAQ: WOOF) and certain officers. The class action, filed in the United States District Court for the Southern District of California, and docketed under 25-cv-01667, is on behalf of a class consisting of all persons and entities other than Defendants that purchased or otherwise acquired Petco securities between January 14, 20 ...
4 Stocks to Buy on Steady Rebound in Manufacturing Activity
ZACKS· 2025-07-07 13:16
Key Takeaways New orders for U.S. factory goods surged 8.2% in May, led by a 230.8% jump in commercial plane demand. ATR, ALLE, BWEN, and DXPE show earnings growth and upward estimate revisions over the past 60 days. Manufacturing recovery hopes rise as inflation eases and potential Fed rate cuts boost investor sentiment.The U.S. manufacturing sector is trying to rebound after suffering for over a year. New orders for U.S.-manufactured goods made a solid rebound in May, with the manufacturing sector showi ...
Pomerantz Law Firm Announces the Filing of a Class Action Against Petco Health and Wellness Company, Inc. and Certain Officers – WOOF
GlobeNewswire News Room· 2025-07-06 14:00
Core Viewpoint - A class action lawsuit has been filed against Petco Health and Wellness Company, Inc. and certain officers for alleged violations of federal securities laws during the Class Period from January 14, 2021, to June 5, 2025, seeking damages for misleading statements regarding the company's business and financial performance [1][8]. Company Overview - Petco is a specialty retailer offering a variety of pet products and services, including consumable and non-consumable products, as well as in-store veterinary and grooming services [4]. - A key business metric for Petco is comparable sales, which measures the change in period-over-period net sales from physical locations and digital sites [4]. Financial Performance and Misrepresentation - Petco claimed to benefit from pandemic-related tailwinds, including increased pet adoption rates, and positioned itself as a health-focused pet company capitalizing on trends of "pet humanization" and "premiumization" [5]. - However, as these pandemic-related tailwinds diminished, Petco's sales and profitability metrics began to decline significantly, with a notable downturn in mid-2023 [6]. - Despite worsening financial conditions, Petco's management continued to affirm optimistic financial guidance for FY 2023, including adjusted EBITDA of $520 million to $540 million and adjusted EPS of $0.40 to $0.48 [7]. Class Action Allegations - The complaint alleges that Petco's management made materially false and misleading statements about the sustainability of its business model and the strength of its product strategy, which were overstated [8]. - Specific allegations include the unsustainability of pandemic-related tailwinds, downplaying the severity of issues affecting sales, and overstating the company's ability to deliver sustainable growth [8]. Recent Financial Disclosures - On August 24, 2023, Petco revised its FY 2023 adjusted EBITDA guidance down to $460 million to $480 million and adjusted EPS to $0.24 to $0.30, leading to a 20.64% drop in stock price [9][10]. - Further negative revisions were made on November 29, 2023, with adjusted EBITDA guidance lowered to approximately $400 million and adjusted EPS to approximately $0.08, resulting in a 28.91% decline in stock price [11][12]. - In March 2024, Petco reported a GAAP net loss of $1.3 billion and acknowledged that its premium product-focused business model was not sustainable [13]. Market Reaction - Following the negative financial disclosures, Petco's stock price experienced significant declines, including a drop to $2.06 per share after the March 2024 results [14]. - On June 5, 2025, Petco reported a 1.3% year-over-year decline in comparable sales, larger than Wall Street estimates, leading to a further 23.2% drop in stock price [17][18].